Tag #Tzield

Showing 1 to 1 of 1 results

europe.chinadaily.com.cn
🌐 85% Global Worthiness
News related image

Sanofi's Tzield Approved in China for Type 1 Diabetes Prevention

Sanofi's Tzield, an injection delaying type 1 diabetes progression, received approval in China, offering a three-year delay to stage 3 for eligible patients, impacting 600,000 individuals.

Progress

36% Bias Score

Good Health and Well-being

Showing 1 to 1 of 1 results